Financial analysts project Eli Lilly stock growth through 2031

Financial analysts say a $5,000 investment in Eli Lilly stock could be worth around $10,100 by 2031. That would mean annual returns of about 15 percent over five years. Analysts expect the company's profits per share to grow by 20 percent each year. However, they also expect the stock's valuation to fall slightly from its current level. Eli Lilly is a large pharmaceutical company. Its recent growth has been driven by a diabetes and weight-loss drug called tirzepatide. Over the past five years, the stock has grown very strongly. A $5,000 investment made five years ago would now be worth about $23,143. Today, Eli Lilly's shares trade at a higher price than most other healthcare companies.